ERVIN GRAVES STRATEGY GROUP, LLC

Lobbying for AMERICAN MEDICINES COMPANY · Manufacturer of Generic Medication

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 16, 2025

Income

$30,000.00

What the client paid this registrant for the period.

Client based in

Virginia

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Health Issues

Appropriations/Funding and Support for strengthening the domestic supply chain for generic medication manufacturing.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.